Aurobindo Pharma Gets FTC Nod For $250 Million Lannett Acquisition

Deal Strengthens US Manufacturing And Expands Complex Generics Portfolio Aurobindo Pharma has received approval from the US Federal Trade Commission (FTC) for its proposed $250 million acquisition of Lannett Company … Continue reading Aurobindo Pharma Gets FTC Nod For $250 Million Lannett Acquisition